Skip to main content
Premium Trial:

Request an Annual Quote

Open Biosystems to Sell Codon's Synthetic Genetics Tech in N. America

NEW YORK (GenomeWeb News) — Open Biosystems will sell and distribute Codon Devices’ BioFAB synthetic genetics platform in North America, Codon said Monday.  
 
Codon said the agreement is part of its effort to extend its BioFAB platform to a broader market. Previously, Codon offered BioFAB only to customers able to meet minimum order requirements.
 
Under the terms of the agreement, Open Biosystems will sell and distribute Codon Devices' gene-synthesis offering to researchers with needs that fall below its “minimum order threshold.”
 
Codon said that the partnership with Open Biosystems is expected to attract a broad range of new customers and will help it expand its presence within academic, government, and other non-profit institutions.  
 
Financial terms of the agreement were not released.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.